8IM1 Stock Overview
Engages in the research and distribution of medical implants in Switzerland. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Implantica AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 2.99 |
| 52 Week High | SEK 4.37 |
| 52 Week Low | SEK 2.16 |
| Beta | 1.32 |
| 1 Month Change | -1.97% |
| 3 Month Change | -14.69% |
| 1 Year Change | 14.78% |
| 3 Year Change | -45.83% |
| 5 Year Change | n/a |
| Change since IPO | -64.19% |
Recent News & Updates
Recent updates
Shareholder Returns
| 8IM1 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -2.8% | -1.7% | -0.4% |
| 1Y | 14.8% | -6.8% | 7.9% |
Return vs Industry: 8IM1 exceeded the German Medical Equipment industry which returned -6.8% over the past year.
Return vs Market: 8IM1 exceeded the German Market which returned 7.9% over the past year.
Price Volatility
| 8IM1 volatility | |
|---|---|
| 8IM1 Average Weekly Movement | 7.2% |
| Medical Equipment Industry Average Movement | 6.4% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 8IM1's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 8IM1's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 49 | Peter Forsell | www.implantica.com |
Implantica AG engages in the research and distribution of medical implants in Switzerland. The company’s lead product candidate is RefluxStop, a passive CE-marked implant for prevention of gastroesophageal reflux disease. It is also involved in the development of eHealth platform, a digital health system to support its pipeline of smart medical implants designed for a safe and secure control and monitoring over the internet; e-InVivo, a sensor implants to monitor a multitude of health parameters and provide diagnostic information, as well as control treatment from inside the body; wireless energizing platform; and AppetiteControl, an implant to treat obesity by controlling appetite.
Implantica AG Fundamentals Summary
| 8IM1 fundamental statistics | |
|---|---|
| Market cap | €847.43m |
| Earnings (TTM) | -€24.65m |
| Revenue (TTM) | €2.00m |
423.3x
P/S Ratio-34.4x
P/E RatioIs 8IM1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 8IM1 income statement (TTM) | |
|---|---|
| Revenue | €2.00m |
| Cost of Revenue | €1.38m |
| Gross Profit | €626.00k |
| Other Expenses | €25.27m |
| Earnings | -€24.65m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 14, 2025
| Earnings per share (EPS) | -0.087 |
| Gross Margin | 31.27% |
| Net Profit Margin | -1,231.07% |
| Debt/Equity Ratio | 0% |
How did 8IM1 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/05 04:18 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Implantica AG is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Christian Lee | Pareto Securities |
| Chien-Hsun Lee | Pareto Securities |